Cash flow Vext Science, Inc.

Equities

VEXT

CA9255401064

Healthcare Facilities & Services

Market Closed - Canadian Securities Exchange Other stock markets 17:19:21 22/01/2026 GMT			5-day change	1st Jan Change
0.2850 ^CAD	0.00%		+5.56%	+11.76%

11-20	Vext Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
11-20	Vext Science, Inc., Q3 2025 Earnings Call, Nov 20, 2025

cef9467e18302f5b78385a78f57bfa.3XsD3mGNHvE17lX1A8iMuCjI9PTH_0k-f5U0lIqJPe0.igk3sAfITaBP2DSMVZHHzhCExseiuydKC-Fw-7nwaYuyOTurCMIziX6lPg

Published financial data: VEXT SCIENCE, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	25.19M	37.24M	35.41M	34.81M	36M
Total Revenues	25.19M	37.24M	35.41M	34.81M	36M
Cost of Goods Sold, Total	14.44M	18.82M	12.31M	22.77M	27.02M
Gross Profit	10.75M	18.42M	23.1M	12.04M	8.98M
Selling General & Admin Expenses, Total	4.22M	4.82M	8.37M	13.46M	10.73M
Stock-Based Compensation (IS)	880K	950K	1.45M	385K	696K
R&D Expenses	159K	150K	-	-	-
Depreciation & Amortization - (IS)	-	-	664K	1.19M	396K
Amortization of Goodwill and Intangible Assets - (IS)	2.14M	3.29M	3.33M	4.85M	8.34M
Other Operating Expenses	126K	1.22M	12.37K	-19K	374K
Other Operating Expenses, Total	7.52M	10.43M	13.83M	19.86M	20.53M
Operating Income	3.23M	7.99M	9.27M	-7.82M	-11.55M
Interest Expense, Total	-27.62K	-35.49K	-2.04M	-3.81M	-3.55M
Interest And Investment Income	379K	739K	112K	157K	220K
Net Interest Expenses	351K	704K	-1.93M	-3.65M	-3.33M
Income (Loss) On Equity Invest.	-521K	-540K	-466K	1.93M	-3.65M
Currency Exchange Gains (Loss)	328K	-10.73K	1.19K	-5.37K	619
Other Non Operating Income (Expenses)	-592K	-899K	1	-	-1.79M
EBT, Excl. Unusual Items	2.8M	7.24M	6.88M	-9.55M	-20.32M
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-425K	-	-	-
Gain (Loss) On Sale Of Assets	-161K	3.2K	20.4K	-811K	-147K
Other Unusual Items	-	-	-200K	13.72M	-651K
EBT, Incl. Unusual Items	2.64M	6.82M	6.7M	3.36M	-21.12M
Income Tax Expense	514K	1.83M	-4.22M	-1.04M	1.31M
Earnings From Continuing Operations	2.13M	4.99M	10.92M	4.4M	-22.44M
Net Income to Company	2.13M	4.99M	10.92M	4.4M	-22.44M
Net Income - (IS)	2.13M	4.99M	10.92M	4.4M	-22.44M
Net Income to Common Incl Extra Items	2.13M	4.99M	10.92M	4.4M	-22.44M
Net Income to Common Excl. Extra Items	2.13M	4.99M	10.92M	4.4M	-22.44M
Per Share Items
Net EPS - Basic	0.02	0.04	0.08	0.03	-0.09
Basic EPS - Continuing Operations	0.02	0.04	0.08	0.03	-0.09
Basic Weighted Average Shares Outstanding	92.77M	137M	139M	164M	241M
Net EPS - Diluted	0.02	0.03	0.08	0.03	-0.09
Diluted EPS - Continuing Operations	0.02	0.03	0.08	0.03	-0.09
Diluted Weighted Average Shares Outstanding	93.53M	146M	140M	165M	241M
Normalized Basic EPS	0.02	0.03	0.03	-0.04	-0.05
Normalized Diluted EPS	0.02	0.03	0.03	-0.04	-0.05
Supplemental Items
EBITDA	5.34M	11.25M	15.52M	1.54M	2.84M
EBITA	3.85M	8.82M	12.42M	-3.2M	-3.99M
EBIT	3.23M	7.99M	9.27M	-7.82M	-11.55M
EBITDAR	5.44M	11.56M	-	-	-
Total Revenues (As Reported)	25.19M	37.24M	-	-	-
Effective Tax Rate - (Ratio)	19.48	26.88	-63.03	-30.8	-6.22
Current Foreign Taxes	-	-	-	-	-
Total Current Taxes	-	-	2.76M	-800K	2.31M
Deferred Foreign Taxes	-	-	-	-	-
Total Deferred Taxes	514K	1.83M	-6.98M	-235K	-992K
Normalized Net Income	1.75M	4.53M	4.3M	-5.97M	-12.7M
Interest on Long-Term Debt	121K	63.62K	119K	209K	413K
Supplemental Operating Expense Items
Advertising Expense	444K	487K	-	-	-
Selling and Marketing Expenses	444K	487K	-	-	-
General and Administrative Expenses	1.91M	2.46M	4.9M	8.33M	5.53M
Research And Development Expense From Footnotes	159K	150K	-	-	-
Net Rental Expense, Total	98.52K	316K	-	-	-
Imputed Operating Lease Interest Expense	2.32K	7.02K	-	-	-
Imputed Operating Lease Depreciation	96.2K	309K	-	-	-
Maintenance & Repair Expenses, Total	445K	265K	-	-	-
Stock-Based Comp., Other (Total)	880K	950K	1.45M	385K	696K
Total Stock-Based Compensation	880K	950K	1.45M	385K	696K

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1.75M	6.47M	5.93M	8.72M	4.62M
Total Cash And Short Term Investments	1.75M	6.47M	5.93M	8.72M	4.62M
Accounts Receivable, Total	17.34M	21.79M	3.12M	1.22M	990K
Other Receivables	648K	614K	174K	42.49K	24.28K
Notes Receivable	1.85M	1.08M	18.99M	7.16M	800K
Total Receivables	19.84M	23.49M	22.28M	8.42M	1.81M
Inventory	857K	215K	12.57M	12.24M	11.74M
Prepaid Expenses	196K	284K	529K	429K	707K
Deferred Tax Assets Current	-	-	756K	-	-
Other Current Assets, Total	1.36M	708K	10.61M	11.47M	7.51M
Total Current Assets	24M	31.16M	52.68M	41.28M	26.4M
Gross Property Plant And Equipment	16.03M	34.75M	46.25M	54.18M	56.83M
Accumulated Depreciation	-3.31M	-5.7M	-9.8M	-13.01M	-17.37M
Net Property Plant And Equipment	12.72M	29.05M	36.45M	41.17M	39.47M
Long-term Investments	1.63M	1.72M	1.76M	1.71M	357K
Goodwill	462K	462K	462K	2.07M	5.14M
Other Intangibles, Total	7.55M	6.71M	27.84M	61.99M	64.26M
Accounts Receivable Long-Term	432K	-	-	-	-
Loans Receivable Long-Term	8.67M	14.6M	1.33M	1.33M	1.35M
Deferred Tax Assets Long-Term	-	-	-	2.5K	-
Other Long-Term Assets, Total	-	-	-	-	-
Total Assets	55.45M	83.7M	121M	150M	137M
Liabilities
Accounts Payable, Total	495K	1.37M	1.98M	2.04M	3.74M
Accrued Expenses, Total	1.98M	1.68M	1.98M	2.41M	3.27M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	6.03M	6.4M	5.8M	5.79M	4.64M
Current Portion of Leases	157K	15.37K	157K	471K	831K
Current Income Taxes Payable	45.63K	-	3.01M	3.24M	5.38M
Other Current Liabilities	117K	264K	54.92K	24.97K	-
Total Current Liabilities	8.83M	9.74M	12.98M	13.98M	17.86M
Long-Term Debt	4.59M	7.43M	31.46M	30.05M	31.08M
Long-Term Leases	702K	251K	737K	2.28M	2.96M
Deferred Tax Liability Non Current	5.01M	6.89M	3.43M	8.26M	9.33M
Total Liabilities	19.14M	24.31M	48.6M	54.58M	61.23M
Common Stock, Total	17.18M	33.85M	34.47M	48.21M	53.49M
Retained Earnings	17.42M	22.4M	33.32M	37.72M	15.29M
Comprehensive Income and Other	1.71M	3.14M	4.12M	9.05M	6.96M
Total Common Equity	36.31M	59.39M	71.92M	94.98M	75.74M
Total Equity	36.31M	59.39M	71.92M	94.98M	75.74M
Total Liabilities And Equity	55.45M	83.7M	121M	150M	137M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	137M	138M	150M	245M	248M
ECS Total Common Shares Outstanding	115M	138M	149M	217M	247M
Book Value / Share	0.32	0.43	0.48	0.44	0.31
Tangible Book Value	28.31M	52.22M	43.62M	30.92M	6.34M
Tangible Book Value Per Share	0.25	0.38	0.29	0.14	0.03
Total Debt	11.49M	14.1M	38.15M	38.6M	39.52M
Net Debt	9.74M	7.64M	32.22M	29.88M	34.89M
Debt Equivalent Oper. Leases	788K	2.53M	-	-	-
Equity Method Investments, Total	1.28M	1.72M	1.76M	1.71M	357K
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	150K	124K	-	-	-
Inventories - Work In Process, Total	-	-	2.26M	1.33M	2.44M
Inventories - Finished Goods, Total	310K	91.02K	10.31M	10.91M	9.3M
Inventories - Others	397K	-	-	-	-
Land - (BS)	341K	2.61M	2.61M	1.82M	2.59M
Buildings, Total	1.44M	15.97M	18.05M	21.23M	21.87M
Machinery, Total	9.61M	11.46M	14.23M	18.85M	18.31M
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	231K	466K	286K

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	2.13M	4.99M	10.92M	4.4M	-22.44M
Depreciation & Amortization - CF	1.52M	2.45M	3.29M	4.97M	7.62M
Amortization of Goodwill and Intangible Assets - (CF)	615K	835K	3.15M	4.62M	7.56M
Depreciation & Amortization, Total	2.14M	3.29M	6.43M	9.59M	15.18M
Amortization of Deferred Charges, Total - (CF)	-	-	-	991K	88.57K
(Gain) Loss From Sale Of Asset	161K	-	-	342K	147K
(Gain) Loss on Sale of Investments - (CF)	-	425K	-	-	-
Asset Writedown & Restructuring Costs	-	-3.2K	-	-	-
(Income) Loss On Equity Investments - (CF)	521K	540K	466K	-1.93M	3.65M
Stock-Based Compensation (CF)	880K	950K	1.45M	385K	696K
Provision and Write-off of Bad Debts	-	-	-	1.25M	-
Other Operating Activities, Total	345K	3.24M	-6.08M	-15.01M	7.39M
Change In Accounts Receivable	-1.68M	-4.67M	-1.24M	1.44M	101K
Change In Inventories	-857K	642K	861K	2.69M	6.89M
Change In Accounts Payable	724K	451K	220K	-110K	1.42M
Change In Income Taxes	-95	-	-	-	-
Change in Other Net Operating Assets	-1.26M	1.83M	-7.11M	382K	-9.84M
Cash from Operations	3.1M	11.68M	5.92M	4.42M	3.29M
Capital Expenditure	-4.06M	-18.78M	-8.86M	-2.74M	-1.47M
Sale of Property, Plant, and Equipment	-	-	-	5.88M	-
Cash Acquisitions	2.74K	-	-8.01M	-6.61M	-3.13M
Investment in Marketable and Equity Securities, Total	-1.54M	-1.08M	-502K	-42.9K	-219K
Other Investing Activities, Total	-7.3M	-7.24M	-12.94M	-1.31M	-624K
Cash from Investing	-12.9M	-27.1M	-30.31M	-4.82M	-5.44M
Long-Term Debt Issued, Total	206K	4.66M	31.91M	1M	1.67M
Total Debt Issued	206K	4.66M	31.91M	1M	1.67M
Long-Term Debt Repaid, Total	-684K	-894K	-8.18M	-14.16M	-3.61M
Total Debt Repaid	-684K	-894K	-8.18M	-14.16M	-3.61M
Issuance of Common Stock	5.51M	18.58M	130K	16.34M	-
Other Financing Activities, Total	-775K	-2.2M	-	-	-
Cash from Financing	4.26M	20.14M	23.86M	3.19M	-1.95M
Net Change in Cash	-5.55M	4.72M	-533K	2.79M	-4.1M
Supplemental Items
Cash Interest Paid	680K	1.01M	-	3.81M	3.55M
Cash Income Tax Paid (Refund)	-	-	-	-	-
Levered Free Cash Flow	-2.43M	-11.34M	-14.81M	12.33M	20.51M
Unlevered Free Cash Flow	-2.41M	-11.32M	-13.53M	13.73M	22.64M
Change In Net Working Capital	3.38M	1.77M	18.35M	-11.37M	-15.46M
Net Debt Issued / Repaid	-478K	3.76M	23.73M	-13.16M	-1.95M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	4.29	7.17	5.67	-3.62	-5.04
Return on Total Capital	5	8.23	6.31	-4.01	-5.8
Return On Equity %	6.86	10.42	16.63	5.27	-26.28
Return on Common Equity	6.86	10.42	16.63	5.27	-26.28
Margin Analysis
Gross Profit Margin %	42.69	49.46	65.23	34.58	24.94
SG&A Margin	16.75	12.95	23.64	38.65	29.8
EBITDA Margin %	21.2	30.2	43.84	4.42	7.9
EBITA Margin %	15.28	23.69	35.07	-9.2	-11.09
EBIT Margin %	12.83	21.45	26.18	-22.48	-32.1
Income From Continuing Operations Margin %	8.43	13.39	30.84	12.63	-62.32
Net Income Margin %	8.43	13.39	30.84	12.63	-62.32
Net Avail. For Common Margin %	8.43	13.39	30.84	12.63	-62.32
Normalized Net Income Margin	6.95	12.15	12.14	-17.14	-35.29
Levered Free Cash Flow Margin	-9.63	-30.46	-41.81	35.43	56.98
Unlevered Free Cash Flow Margin	-9.56	-30.4	-38.21	39.43	62.9
Asset Turnover
Asset Turnover	0.53	0.54	0.35	0.26	0.25
Fixed Assets Turnover	2.34	1.78	1.08	0.9	0.89
Receivables Turnover (Average Receivables)	1.53	1.9	2.84	16.04	32.6
Inventory Turnover (Average Inventory)	-	35.11	1.93	1.84	2.25
Short Term Liquidity
Current Ratio	2.72	3.2	4.06	2.95	1.48
Quick Ratio	2.23	2.97	0.71	0.71	0.32
Operating Cash Flow to Current Liabilities	0.35	1.2	0.46	0.32	0.18
Days Sales Outstanding (Average Receivables)	239.63	191.74	128.39	22.75	11.23
Days Outstanding Inventory (Average Inventory)	-	10.39	189.57	198.85	162.41
Average Days Payable Outstanding	-	18.72	24.76	30.43	39.88
Cash Conversion Cycle (Average Days)	-	183.41	293.2	191.17	133.76
Long Term Solvency
Total Debt/Equity	31.63	23.74	53.05	40.64	52.18
Total Debt / Total Capital	24.03	19.19	34.66	28.89	34.29
LT Debt/Equity	14.58	12.93	44.77	34.05	44.95
Long-Term Debt / Total Capital	11.08	10.45	29.25	24.21	29.54
Total Liabilities / Total Assets	34.52	29.04	40.32	36.49	44.7
EBIT / Interest Expense	117.06	225.08	4.54	-2.05	-3.25
EBITDA / Interest Expense	194.43	317.76	7.7	0.46	1.02
(EBITDA - Capex) / Interest Expense	47.32	-211.55	3.36	-0.25	0.61
Total Debt / EBITDA	2.14	1.25	2.43	21.82	10.91
Net Debt / EBITDA	1.81	0.68	2.05	16.89	9.63
Total Debt / (EBITDA - Capex)	8.79	-1.88	5.57	-39.86	18.32
Net Debt / (EBITDA - Capex)	7.45	-1.02	4.71	-30.86	16.17
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	12.86	47.83	-4.92	-1.69	3.4
Gross Profit, 1 Yr. Growth %	10.42	71.27	40.57	-47.88	-25.42
EBITDA, 1 Yr. Growth %	21.55	110.58	38.03	-90.1	84.97
EBITA, 1 Yr. Growth %	7.42	129.24	40.75	-125.78	24.76
EBIT, 1 Yr. Growth %	-9.75	147.03	16.07	-184.39	47.67
Earnings From Cont. Operations, 1 Yr. Growth %	-23.92	134.66	118.97	-59.72	-610.07
Net Income, 1 Yr. Growth %	-23.92	134.66	118.97	-59.72	-610.07
Normalized Net Income, 1 Yr. Growth %	-20.66	158.62	-5.03	-238.85	112.84
Diluted EPS Before Extra, 1 Yr. Growth %	-43.51	50	162.14	-65.99	-448.25
Accounts Receivable, 1 Yr. Growth %	10.77	25.68	-85.68	-60.98	-18.72
Inventory, 1 Yr. Growth %	-	-74.94	5.75K	-2.66	-4.09
Net Property, Plant and Equip., 1 Yr. Growth %	44.26	128.42	25.48	12.95	-4.13
Total Assets, 1 Yr. Growth %	43	50.94	43.98	24.1	-8.42
Tangible Book Value, 1 Yr. Growth %	10.25	84.49	-16.47	-29.11	-79.5
Common Equity, 1 Yr. Growth %	41.44	63.56	21.09	32.07	-20.26
Cash From Operations, 1 Yr. Growth %	-887.81	276.99	-47.39	-22.68	-25.68
Capital Expenditures, 1 Yr. Growth %	-22.74	362.26	-52.83	-69.11	-46.46
Levered Free Cash Flow, 1 Yr. Growth %	-57.95	367.4	23.88	-209.23	66.31
Unlevered Free Cash Flow, 1 Yr. Growth %	-58.22	369.83	19.52	-237.03	64.97
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	16.77	29.17	18.55	-3.32	0.83
Gross Profit, 2 Yr. CAGR %	8.44	37.52	46.55	-14.41	-37.66
EBITDA, 2 Yr. CAGR %	-7.16	59.99	70.49	-63.03	-57.21
EBITA, 2 Yr. CAGR %	-17.32	56.93	79.63	-39.77	-43.29
EBIT, 2 Yr. CAGR %	-24.21	49.31	69.33	-1.03	11.64
Earnings From Cont. Operations, 2 Yr. CAGR %	-24.71	33.61	126.68	-6.08	43.34
Net Income, 2 Yr. CAGR %	-24.71	33.61	126.68	-6.08	43.34
Normalized Net Income, 2 Yr. CAGR %	-29.17	43.25	56.72	14.83	71.91
Diluted EPS Before Extra, 2 Yr. CAGR %	-41.05	-7.95	98.29	-5.59	8.82
Accounts Receivable, 2 Yr. CAGR %	14.58	17.99	-57.57	-76.36	-43.68
Inventory, 2 Yr. CAGR %	240.43	-	282.97	654.77	-3.37
Net Property, Plant and Equip., 2 Yr. CAGR %	76.5	81.53	69.3	19.05	4.06
Total Assets, 2 Yr. CAGR %	53.83	46.92	47.42	33.67	6.61
Tangible Book Value, 2 Yr. CAGR %	29.03	42.62	24.14	-23.05	-61.88
Common Equity, 2 Yr. CAGR %	46.15	52.1	40.73	26.46	2.62
Cash From Operations, 2 Yr. CAGR %	13.4	444.98	38.26	-37.31	-24.19
Capital Expenditures, 2 Yr. CAGR %	64.43	88.98	47.67	-61.83	-59.33
Levered Free Cash Flow, 2 Yr. CAGR %	43.22	40.19	147	1.59	34.78
Unlevered Free Cash Flow, 2 Yr. CAGR %	42.71	40.1	136.97	10.11	50.35
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	19.27	26.32	16.63	11.38	-1.13
Gross Profit, 3 Yr. CAGR %	8.67	26.28	33.35	3.83	-18.25
EBITDA, 3 Yr. CAGR %	-4.51	21.98	52.31	-33.98	-36.77
EBITA, 3 Yr. CAGR %	-12.38	16.16	51.34	-5.96	-23.22
EBIT, 3 Yr. CAGR %	-17.32	12.37	37.29	34.25	13.09
Earnings From Cont. Operations, 3 Yr. CAGR %	-19.72	9.98	57.53	27.44	65.08
Net Income, 3 Yr. CAGR %	-19.72	9.98	57.53	27.44	65.08
Normalized Net Income, 3 Yr. CAGR %	-20.79	9.07	24.9	50.52	41.05
Diluted EPS Before Extra, 3 Yr. CAGR %	-31.81	-19.52	30.48	10.17	45.88
Accounts Receivable, 3 Yr. CAGR %	23.87	18.17	-41.58	-58.74	-64.32
Inventory, 3 Yr. CAGR %	45.28	42.68	-	142.59	279.46
Net Property, Plant and Equip., 3 Yr. CAGR %	54.18	92.35	60.51	47.94	10.76
Total Assets, 3 Yr. CAGR %	58.83	52.86	45.93	39.2	17.84
Tangible Book Value, 3 Yr. CAGR %	47.76	45.37	19.32	2.99	-50.49
Common Equity, 3 Yr. CAGR %	60.55	51.74	40.97	37.78	8.44
Cash From Operations, 3 Yr. CAGR %	18.35	69.24	146.94	12.61	-33.65
Capital Expenditures, 3 Yr. CAGR %	53.12	132.07	18.99	-12.34	-57.27
Levered Free Cash Flow, 3 Yr. CAGR %	-	112.44	36.9	71.93	19.73
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	112.3	32.88	78.59	25.99
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	18.98	13.51	10.03
Gross Profit, 5 Yr. CAGR %	-	-	22.48	5.65	-1.62
EBITDA, 5 Yr. CAGR %	-	-	20.4	-24.33	-8.34
EBITA, 5 Yr. CAGR %	-	-	16.77	-10.68	2.2
EBIT, 5 Yr. CAGR %	-	-	10.14	6.81	26.39
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	21.6	3.25	51.69
Net Income, 5 Yr. CAGR %	-	-	21.6	3.25	51.69
Normalized Net Income, 5 Yr. CAGR %	-	-	4.06	11.34	41.93
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	4.51	-14.21	21.34
Accounts Receivable, 5 Yr. CAGR %	-	-	-19.3	-37.92	-42.43
Inventory, 5 Yr. CAGR %	-	-	114.09	177.81	-
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	60.06	58.76	34.96
Total Assets, 5 Yr. CAGR %	-	-	54.16	44.87	28.71
Tangible Book Value, 5 Yr. CAGR %	-	-	37.81	12.71	-24.41
Common Equity, 5 Yr. CAGR %	-	-	52.31	41.07	24.16
Cash From Operations, 5 Yr. CAGR %	-	-	25.95	12.92	52.92
Capital Expenditures, 5 Yr. CAGR %	-	-	50.92	12.74	-22.56
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	59.81	28.87
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	63.27	31.46